{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:07:57Z","timestamp":1759018077648,"version":"3.44.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1053\/jinf.2002.1102","type":"journal-article","created":{"date-parts":[[2003,3,25]],"date-time":"2003-03-25T21:15:53Z","timestamp":1048626953000},"page":"149-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["HIV-associated Lipodystrophy Syndrome: Description and Pathogenesis"],"prefix":"10.1016","volume":"46","author":[{"given":"N.","family":"Bodasing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jinf.2002.1102_RF1","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/jinf.2002.1102_RF3","first-page":"861","article-title":"Buffalo Hump in HIV infected patients on antiretroviral therapy","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/jinf.2002.1102_RF4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1468-1293.2001.00073.x","article-title":"The prevalence of lipodystrophy in an ambulant HIV-infected poulation: it all depends on the definition","volume":"2","author":"Carter","year":"2001","journal-title":"HIV Med"},{"key":"10.1053\/jinf.2002.1102_RF5","unstructured":"Grunfeld, C, Basic science and metabolic disturbances, 2002, Barcelona, Spain"},{"key":"10.1053\/jinf.2002.1102_RF6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/ajcn\/42.6.1255","article-title":"Body composition studies in patients with the acquired immunodeficiency syndrome","volume":"42","author":"Kotler","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/jinf.2002.1102_RF7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study","volume":"14","author":"Saint-Marc","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF8","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jinf.2002.1102_RF9","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"79","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jinf.2002.1102_RF10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0009-8981(98)00050-3","article-title":"Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers","volume":"274","author":"Fernandez-Miranda","year":"1998","journal-title":"Clin Chim Acta"},{"key":"10.1053\/jinf.2002.1102_RF11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","article-title":"Hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"86","author":"Grunfeld","year":"1989","journal-title":"Am J Med"},{"key":"10.1053\/jinf.2002.1102_RF12","first-page":"559","article-title":"Increased de novo hepatic lipogenesis in human immunodeficiency virus infected humans","volume":"76","author":"Hellerstein","year":"1993","journal-title":"J Endocrinol Metab"},{"key":"10.1053\/jinf.2002.1102_RF13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9343(91)90536-7","article-title":"Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"90","author":"Grunfeld","year":"1991","journal-title":"Am J Med"},{"key":"10.1053\/jinf.2002.1102_RF14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0026-0495(90)90136-Z","article-title":"Protein and energy substrate metabolism in AIDS patients","volume":"39","author":"Stein","year":"1990","journal-title":"Metabolism"},{"key":"10.1053\/jinf.2002.1102_RF15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0026-0495(91)90059-6","article-title":"Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men","volume":"40","author":"Hommes","year":"1991","journal-title":"Metabolism"},{"key":"10.1053\/jinf.2002.1102_RF16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00002030-199907300-00013","article-title":"Fasting hyperinsulinemia and increased waisit-to-hip ratios in non-wasting individuals with AIDS","volume":"13","author":"Shikuma","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF17","first-page":"1932","article-title":"Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women","volume":"84","author":"Hadigan","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jinf.2002.1102_RF18","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF20","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors is associated with peripheral insulin resistance and impaired glucose tolerance in HIV-1 infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF21","article-title":"Metabolic changes in HIV-infected patients treated with protease inhibitors","author":"Bernasconi","year":"1998","journal-title":"Program and Abstracts of the 12th World AIDS Conference"},{"key":"10.1053\/jinf.2002.1102_RF22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/jinf.2002.1102_RF23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02560501","article-title":"Hyperlipidaemia under treatment with protease inhibitors","volume":"27","author":"Sergerer","year":"1999","journal-title":"Infection"},{"key":"10.1053\/jinf.2002.1102_RF24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-978655","article-title":"HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study","volume":"32","author":"Petit","year":"2000","journal-title":"Horm Metab Res"},{"key":"10.1053\/jinf.2002.1102_RF25","first-page":"12387","article-title":"Hyperglycaemia associated with protease inhibitor therapy","author":"Montserrat","year":"1998","journal-title":"Program and Abstracts of XII International Conference on AIDS"},{"key":"10.1053\/jinf.2002.1102_RF26","article-title":"Reports of diabetes and hyperglycaemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus","author":"Lumpkin","year":"1997","journal-title":"FDA Public Health Advisory"},{"key":"10.1053\/jinf.2002.1102_RF27","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study","volume":"160","author":"Tsiodras","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/jinf.2002.1102_RF28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00002030-199905070-00009","article-title":"Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine","volume":"13","author":"Martinez","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF29","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"352","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/jinf.2002.1102_RF30","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1677\/joe.0.164r007","article-title":"HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma\/RXR heterodimer","volume":"164","author":"Wentworth","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1053\/jinf.2002.1102_RF31","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1210\/jcem.84.11.6234","article-title":"Inhibition of adipocyte differentiation by HIV protease inhibitors","volume":"84","author":"Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jinf.2002.1102_RF32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00041433-200106000-00004","article-title":"The sterol regulatory element-binding protein pathway: control of lipid homeostasis through regulated intracellular transport","volume":"12","author":"Sakai","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.1053\/jinf.2002.1102_RF33","first-page":"352","article-title":"HIV protease inhibitor-induced hyperlipidaemia and lipodystrophy is mediated through regulation of sterol responsive element-binding protein (SREPB) responsive genes","volume":"102","author":"Kuhel","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/jinf.2002.1102_RF34","doi-asserted-by":"crossref","first-page":"13120","DOI":"10.1073\/pnas.95.22.13120","article-title":"An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses","volume":"95","author":"Andre","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/jinf.2002.1102_RF35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm1201-1327","article-title":"HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia","volume":"7","author":"Liang","year":"2001","journal-title":"Nat Med"},{"key":"10.1053\/jinf.2002.1102_RF36","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"10.1053\/jinf.2002.1102_RF37","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","article-title":"Alteration of tumour necrosis factor-alpha T-cell hoemeostasis following potent antiretroviral therapy: contribution to the developement of human immunodefieiency virus-associated lipodystrophy syndrome","volume":"95","author":"Ledru","year":"2000","journal-title":"Blood"},{"key":"10.1053\/jinf.2002.1102_RF38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumour necrosis factor receptor levels in HIV lipodystrophy","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J Acquir Immun Def Syndr"},{"key":"10.1053\/jinf.2002.1102_RF39","article-title":"Acylation stimulating protein (ASP) and tumour necrosis factor (TNF) production in subcutaneous adipose tissue of HIV-infected patients with and without lipodystrophy","author":"Ionescu","year":"2002","journal-title":"Program and Abstracts of the XIV International AIDS Conference"},{"key":"10.1053\/jinf.2002.1102_RF40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dube","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/jinf.2002.1102_RF41","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/jinf.2002.1102_RF42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/diabetes.50.6.1397","article-title":"The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle","volume":"50","author":"Nolte","year":"2001","journal-title":"Diabetes"},{"key":"10.1053\/jinf.2002.1102_RF43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00002030-199904160-00020","article-title":"Lipodystrophy in patients na\u0131̈ve to HIV protease inhibitors","volume":"13","author":"Madge","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleopside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jinf.2002.1102_RF46","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.43.6.1200","article-title":"Clinical features associated with the A\u2192G transition at nucleotide 8344 of mtDNA (\u201cMERRF mutation\u201d)","volume":"43","author":"Silvestri","year":"1993","journal-title":"Neurology"},{"key":"10.1053\/jinf.2002.1102_RF47","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI108881","article-title":"Multiple symmetric lipomatosis: a defect in adrenergic-stimulated lipolysis","volume":"60","author":"Enzi","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1053\/jinf.2002.1102_RF48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0899-9007(99)00111-2","article-title":"Correlation between increased cortisol:DHEA ratio and malnutrition in HIV-positive men","volume":"15","author":"Christeff","year":"1999","journal-title":"Nutrition"},{"key":"10.1053\/jinf.2002.1102_RF49","first-page":"803","article-title":"Steroid hormones, cytokines, lipid and metabolic disturbances in HIV infection","author":"Nunez","year":"1994","journal-title":"The Endocrinology and Metabolism of HIV Infection"},{"key":"10.1053\/jinf.2002.1102_RF50","first-page":"841","article-title":"Evidence for changes in adrenal and testicular steroids during HIV infection","volume":"5","author":"Christeff","year":"1992","journal-title":"J Acquir Immun Def Syndr"},{"key":"10.1053\/jinf.2002.1102_RF51","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/00002030-199911120-00007","article-title":"Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations","volume":"13","author":"Christeff","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF52","first-page":"E123","article-title":"Metabolic alteration after dehyroepiandrosterone treatment in Zucker rats","volume":"246","author":"Shepherd","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1053\/jinf.2002.1102_RF53","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1210\/jcem.84.6.5740","article-title":"Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy","volume":"84","author":"Yanovski","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jinf.2002.1102_RF54","first-page":"3734","article-title":"Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome","volume":"82","author":"Grunfeld","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jinf.2002.1102_RF55","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(99)01449-X","article-title":"Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitors","volume":"353","author":"Lister","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jinf.2002.1102_RF56","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/00002030-200112070-00007","article-title":"An interaction between apo-C-III variants and protease inhibitors contributes to high triglycerides\/low HDL levels intreated patients","volume":"15","author":"Fauvel","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF57","first-page":"28","article-title":"Protease inhibitors and NRTI reverse transcriptase inhibitors interact to cause subcutaneous fat wasting in patients with HIV infection","volume":"4","author":"Mallal","year":"1999","journal-title":"Antiviral Therp"},{"key":"10.1053\/jinf.2002.1102_RF58","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor\u2014related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/jinf.2002.1102_RF59","article-title":"Changes in body shape during PI therapy in HIV +ve women","author":"Sutinen","year":"1999","journal-title":"Program and Abstracts of 6th Conference on Retroviruses and Opportunistic Infections"},{"key":"10.1053\/jinf.2002.1102_RF60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(05)60293-0","article-title":"Buffalo Hump in HIV infection","volume":"352","author":"Saint-Marc","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/jinf.2002.1102_RF61","article-title":"\u201cProtease paunch\u201d in HIV +ve persons receiving protease inhibitor therapy:incidence, risk and endocrinologic evaluation","author":"Rosenberg","year":"1998","journal-title":"Program and Abstracts of the Fifth Conference on Retroviruses and Opportunistic Infections"},{"key":"10.1053\/jinf.2002.1102_RF62","article-title":"Expanding the spectrum of protease inhibitors-induced lipodystrophy","author":"Boix","year":"1998","journal-title":"Program and Abstracts of 12th World AIDS Conference"},{"key":"10.1053\/jinf.2002.1102_RF63","article-title":"Changes in body habitus in HIV infected patients treated with protease inhibitors","author":"Reboli","year":"1998","journal-title":"Infectious Diseases Society of America 36th Annual Meeting"},{"key":"10.1053\/jinf.2002.1102_RF64","first-page":"107","article-title":"Changes in body habitus and serum lipid abnormalities in HIV +ve women on highly active antiretroviral therapy","volume":"21","author":"Dong","year":"1999","journal-title":"J Acquir Immun Def Syndr Retrovirol"},{"key":"10.1053\/jinf.2002.1102_RF65","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/517654","article-title":"Another case of breast hypertrophy in a patient treated with Indinavir","volume":"26","author":"Lui","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jinf.2002.1102_RF66","article-title":"Indinavir associated facial atrophy in HIV positive patients","author":"Wong","year":"1998","journal-title":"Program and abstracts of 12th World AIDS Conference"},{"key":"10.1053\/jinf.2002.1102_RF67","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","article-title":"Indinavir-associated lipodystrophy","volume":"12","author":"Viraben","year":"1998","journal-title":"AIDS"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445302911023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445302911023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:25:02Z","timestamp":1758986702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445302911023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0163445302911023"],"URL":"https:\/\/doi.org\/10.1053\/jinf.2002.1102","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-associated Lipodystrophy Syndrome: Description and Pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/jinf.2002.1102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}